FORMELA JEAN FRANCOIS sold $34K of KRRO (indirect holdings)
FORMELA JEAN FRANCOIS sold 2,441 indirectly-held shares of Korro Bio, Inc. (KRRO) at $13.95 on 2026-05-28 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Insider sales under 10b5-1 plans are generally viewed as less informative than discretionary sales, so the event is more sentiment/positioning-related than fundamental.
Market read
A routine 10b5-1 insider sale disclosure for KRRO with limited expected impact beyond minor sentiment.
What to watch
The sale size ($34k) is relatively small versus typical biotech market caps, and the indirect ownership detail may further reduce signal strength.
Background
The article is an SEC Form 4 insider transaction disclosure for Korro Bio, Inc.
Ticker impact
Korro Bio director sold 2,441 shares in an open-market transaction under a pre-arranged 10b5-1 plan on May 28.
Low likelihood of a sustained price move; any reaction is likely muted and short-lived.
The filing is a routine Form 4 insider sale and explicitly tied to a pre-arranged 10b5-1 plan, reducing interpretive signal.
Market effects
No clear sector read-through from a single 10b5-1 director sale.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated insider selling can still coincide with weaker near-term expectations; traders may monitor for follow-on sales.
Key entities
- issuerKorro Bio, Inc.
Subject of the insider transaction disclosure; director sold shares under a pre-arranged 10b5-1 plan.
- insiderFORMELA JEAN FRANCOIS
Director who executed the open-market sale disclosed on Form 4.